Obesity, a world epidemics. Genetic implications;Obesidad, una epidemia mundial. Implicaciones de la genética

Revista Cubana de Investigaciones Biomedicas

Volumn 26, Issue 3, 2007, Pages

  Triana, Manuel Hernández ^a   Álvarez, Vladimir Ruiz ^b  

^a Instituto de Nutricion e Higiene de los Alimentos   (Cuba)

^b NONE

Author keywords

Cuba; Genetics; Nutrigenetics; Nutrigenomic; Obesity; Prevalence

Indexed keywords

EID: 42549100027     PISSN: 08640300     EISSN: 15613011     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Who Global Infobase On-Line. Consultado Abril 2, 2007. Disponible en: http://www.who.int/ncd_surveillance/infobase/web/web
2. Jiménez Acosta S, Díaz ME, Barroso I, Bonet M, Cabrera A, Wong I. Estado nutricional de la población cubana adulta. Rev Esp Nutr Comunitaria 2005;11(1):18-26.
3. Fernández-Britto JE, Barriuso A, Chiang MT. La señal aterogénica temprana: estudio multinacional de 4 934 niños y jóvenes y 1 278 autopsias. Rev Cubana Invest Biomed 2005;24(3). Disponible en: http://bvs.sld.cu/revistas/
4. Jiménez S, Monterrey P, Plasencia D. Vigilancia nutricional materno-infantil mediante sitios centinela, Cuba 2002, La Habana, Cuba: Instituto de Nutrición e Higiene de los Alimentos; 2002.
5. Ministerio de Salud Pública. Estudio Nacional de Crecimiento y Desarrollo. Grupo Nacional de Crecimiento y Desarrollo, La Habana:MINSAP; 1986.
6. Jiménez S, Monterrey P, Plasencia D. Vigilancia nutricional materno-infantil mediante sitios centinela, Cuba 1988-1989, La Habana: Instituto de Nutrición e Higiene de los Alimentos, 1990.
7. Chiang A. Acerca del estado de nutrición de niños menores de 5 años en localidades rurales según el abastecimiento de agua. Rev Cubana Aliment Nutr 1991;5:56-9.
8. Hernández M, Vaillant G, Vargas E. Malnutrición por exceso en niños menores de 1 año de la Regional Guantánamo. Rev Cubana Pediat 1977;49:19-26.
9. a Sesión Del Comité Regional. CD47/18; 2006.
10. Organización Panamericana de la Salud. Plan Estratégico para la Oficina Sanitaria Panamericana, 2003-2007. Washington, DC: OPS; 2002. (Documents CSP26/10).
11. Organización Mundial de la Salud. Informe Mundial de la OMS. Prevención de las enfermedades crónicas: una inversión vital. Ginebra:OMS; 2005.
12. a Sesión del Comité Regional, CD47/17, Rev. 1, EUA; 2006.
13. McMille C, Robinson JS. Developmental Origins of the Metabolic Syndrome: Prediction, Plasticity and Programming. Physiol Rev 2005;85:571-633.
14. Preventing Childhood Obesity. Health in the Balance. Committee on Prevention of Obesity in Children and Youth. Food and Nutrition Board. Board on Health Promotion and Disease Pevention. Institute of Medicine of the National Academies. Washington, D.C.: The National Academies Press; 2005. ISBN 0-309-09315-5.
15. Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr 2004;134:205-10.
16. Ozanne SE, Fernandez-Twinn D, Hales CN. Fetal growth and adult diseases. Semin Perinatol 2004;28:81-7.
17. Koletzko B, Dodds P, Akerblom H, Ashwell M eds. Early nutrition and later health: new opportunities. Berlin:Springer;2005.
18. Monteiro POA, Victora CG. Rapid growth in infancy and childhood and obesity in later life-a systematic review. Obesity Rew 2005;6:43-154.
19. Buchan IE, Heller RF, Clayton P, Bundred PE, Cole TJ. Early life risk factors for obesity in childhood: early feeding is crucial target for preventing obesity in children. BMJ 2005;331(7514):453-4.
20. Pate RR, Dowda M, Ross JG. Associations between physical activity and physical fitness in American children. Am J Dis Child 1990;144:1123-9.
21. Pisabarro R. Nutrigenética y nutrigenómica: la revolución sanitaria del nuevo milenio. Implicancias clínicas en síndrome metabólico y diabetes tipo 2. Rev Med Urug 2006;22:100-7.
22. Desiere F. Towards a systems biology understanding of human health: Interplay between genotype, environment and nutrition. Biotechnol Annu Rev 2004;10:51-84.
23. Fenech M. Genome health nutrigenomics: nutrition and the science of optimal genome maintenance. Asia Pac J Clin Nutr 2004;13(Suppl):S15.
24. Match DM, Wahli W, Williamson G. Nutrigenomics and Nutrigenetics:the emerging faces of nutrition. FASEB J 2005;19:1602-16.
25. Beck MA, Levander OA, Handy J. Selenium deficiency and viral infection. J Nutr 2003;133:1463S-67S.
26. Beck MA, Levander OA. Dietary oxidative stress and the potentiation of viral infection. Annu Rev Nutr 1998;18:93-116.
27. Stover P. Influence of human genetic variation on nutritional requirements. Am J Clin Nutr 2006;83(suppl):436S-42S.
28. Salmeron J, Hu FB, Manson JE. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001;73:1019-26.
29. Palou A, Bonet ML, Picó C. Nutrigenómica y obesidad. Rev Med Univ Navarra 2004;48(2):36-48.
30. Chagnon YC, Rankinen T, Zinder EE. The human obesity gene map:the 2002 update. Obes Res 2003;11:313-67.
31. Bouchard C, Tremblay A, Despres JP. The response to long-term overfeeding in identical twins. N Engl J Med 1990;322:1477-82.
32. Arner P, Hoffsted F. Adrenoreceptor genes in human obesity. J Intern Med 1999;6:667-72.
33. Evans D, Minouchehr S, Hagemann G. Frequency of an interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans. Int J Obes Rel Metab Disord 2000;24:1239-45.
34. Green SA, Turki J, Innis M. Aminoterminal polymorphisms of the human beta2 adrenergic receptor impart distinct agonist-pro,oted regulatory properties. Biochemistry 1994;33:9414-9.
35. González-Sánchez JL, Proenza AM, Martínez-Larrad MT. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoreceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. Clin Endocrinol 2003;59:476-81.
36. Dalziel B, Gosby AK, Richman. Association of the TNF-alpha-308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 2002;10:401-7.
37. Cox NJ. Calpain 10 and genetics of type 2 diabetes. Current Diabetes Rep 2002;2:186-90.
38. Baier LJ, Permana PA, Yang X. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000;106:R69-R73.
39. Meyre D, Bouatia-Naji N, Tounian A. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nature Genet 2005;37:863-7.
40. Gu HF, Alegren P, Lindholm E. Association between the human glycoprotein PC-1 gene and elevated glucosa and insulin levels in a paired-sibling analysis. Diabetes 2000;49:1601-3.
41. Dahlman I, Kaaman M, Jiao H. The CIDEA gene V115F polymorphism is associated with obesity in Swedish subjects. Diabetes 2005;54:3032-4.
42. Altshuler D, Hirshhorn JN, Klannemark M. The common PPAR gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 2000;26:76-80.
43. Juhi CB, Hollingdal M, Porsken N. Influence of rosiglitazone treatment on beta cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility. J Clin Endocrinol Metab 2003;88(8):3794-800.
44. Steppan CM, Bailey ST, Bhat S. The hormone resistant links obesity to diabetes. Nature 2001;409:307-12.
45. Hegele RA, Cao H, Harris SB. Peroxisome proliferator-activated receptor gamma2 P12A and type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 2000;85:2014-9.
46. Pisabarro RE, Sanguinetti C, Stoll M, Prendez D. High incidence of type 2 diabetes in peroxisome-proliferator-activated receptor gamma 2 Pro12Alacarriers exposed to a high chronic intake of trans fatty acids and saturated fatty acids. Diabetes Care 2004;27(9):2251-2.
47. Hallman DM, Boerwinkle E, Saha N. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-49.
48. Zee RY, Griffiths LR, Morris BJ. Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertension. Biochem Biophys Res Commun 1992;189:965-71.
49. Sivenius K, Valve R, Lindi V. Synergic effect of polymorphisms in uncoupling protein 1 (UCP1) and Beta 3-adrenergic receptor genes on long-term body weight change in Finnish type 2 diabetic and non diabetic control subjects. Int J Obes 2000;24:514-9.
50. Meirhaeghe A, Helbecque N, Cottel D. Beta 2- adrenoreceptor gene polymorphism, body weight, and physical activity. Lancet 1999;353:896.